NDC Package 68180-894-73 Drospirenone, Ethinyl Estradiol And Levomefolate Calcium And Levomefolate Calcium

Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

68180-894-73

Package Description:

3 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK

Product Code:

68180-894

Proprietary Name:

Drospirenone, Ethinyl Estradiol And Levomefolate Calcium And Levomefolate Calcium

Non-Proprietary Name:

Drospirenone, Ethinyl Estradiol And Levomefolate Calcium And Levomefolate Calcium

Usage Information:

Drospirenone, ethinyl estradiol and levomefolate calcium tablet and levomefolate calcium tablet is contraindicated in females who are known to have or develop the following conditions:Renal impairmentAdrenal insufficiencyA high risk of arterial or venous thrombotic diseases. Examples include women who are known to:Smoke, if over age 35 [see Boxed Warning and Warnings And Precautions (5.1)]Have deep vein thrombosis or pulmonary embolism, now or in the past [see Warnings And Precautions (5.1)]Have cerebrovascular disease[see Warnings And Precautions (5.1)]Have coronary artery disease[see Warnings And Precautions (5.1)]Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see Warnings And Precautions (5.1)]Have inherited or acquired hypercoagulopathies [see Warnings And Precautions (5.1)]Have uncontrolled hypertension [see Warnings And Precautions (5.6)]Have diabetes mellitus with vascular disease [see Warnings And Precautions (5.8)]Have headaches with focal neurological symptoms or have migraine headaches with or without aura if over age 35 [see Warnings And Precautions (5.9)]Undiagnosed abnormal uterine bleeding [see Warnings And Precautions (5.10)]Current diagnosis of, or history of, breast cancer, which may be hormone-sensitive [see Warnings And Precautions (5.3)]Liver tumors, benign or malignant, or liver disease [see Warnings And Precautions (5.4) and Use In Specific Populations (8.7)]Pregnancy, because there is no reason to use COCs during pregnancy [see Warnings And Precautions (5.11) and Use In Specific Populations (8.1)]Use of Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir due to the potential for ALT elevations [see Warnings And Precautions (5.5) and Drug Interactions (7.3)].

11-Digit NDC Billing Format:

68180089473

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

3 EA

NDC to RxNorm Crosswalk:

RxCUI: 1013626 - drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet

RxCUI: 1013628 - levomefolate calcium 0.451 MG Oral Tablet

RxCUI: 1013629 - {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack

RxCUI: 1013629 - Drospiren-Eth estra-Levomefol Ca 3-0.02-0.451 MG (24) Oral Tablet / Levomefol Ca 0.451 MG (4) Oral Tablet 28 Day Pack

Product Type:

Human Prescription Drug

Labeler Name:

Lupin Pharmaceuticals, Inc.

Dosage Form:

Kit - A packaged collection of related material.

Sample Package:

FDA Application Number:

ANDA205947

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

08-22-2018

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

68180 - Lupin Pharmaceuticals, Inc.
- 68180-894 - Drospirenone, Ethinyl Estradiol And Levomefolate Calcium And Levomefolate Calcium
  - 68180-894-73 - 3 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 68180-894-73?

The NDC Packaged Code 68180-894-73 is assigned to a package of 3 pouch in 1 carton / 1 blister pack in 1 pouch / 1 kit in 1 blister pack of Drospirenone, Ethinyl Estradiol And Levomefolate Calcium And Levomefolate Calcium, a human prescription drug labeled by Lupin Pharmaceuticals, Inc.. The product's dosage form is kit and is administered via form.

Is NDC 68180-894 included in the NDC Directory?

Yes, Drospirenone, Ethinyl Estradiol And Levomefolate Calcium And Levomefolate Calcium with product code 68180-894 is active and included in the NDC Directory. The product was first marketed by Lupin Pharmaceuticals, Inc. on August 22, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 68180-894-73?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 3.

What is the 11-digit format for NDC 68180-894-73?

The 11-digit format is 68180089473. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	68180-894-73	5-4-2	68180-0894-73

Table of Contents